Clearance Summary
Stereotaxis Genesis RMN with Navigant Workstation (NWS) and Cardiodrive System received FDA 510(k) clearance under submission number K193147, sponsored by Stereotaxis, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2020-03-05.
- Submission: K193147
- Applicant / Sponsor: Stereotaxis, Inc.
- Clearance pathway: Traditional
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.5700
- Decision date: 2020-03-05
Classification & Regulation
This clearance is catalogued under FDA product code PJB and 21 CFR 870.5700, within the Cardiovascular review panel as a Class II device.